Topic

Pemazyre (pemigatinib)

A collection of 15 issues

How to Get Pemazyre (Pemigatinib) Covered by Aetna CVS Health in Washington: Appeals, Forms & Timelines

Answer Box: Getting Pemazyre Covered by Aetna CVS Health in Washington Pemazyre (pemigatinib) requires prior authorization from Aetna CVS Health and is typically non-formulary, requiring a formulary exception. Key requirements: FDA-approved test confirming FGFR2 fusion/rearrangement, previous systemic therapy failure, and comprehensive clinical documentation. First step: Have your oncologist submit

If Pemazyre (Pemigatinib) Isn't Approved by Aetna CVS Health in Ohio: Formulary Alternatives & Exception Paths

Answer Box: Fast Track to Pemazyre Coverage If Aetna CVS Health denies Pemazyre (pemigatinib) in Ohio, you have three main paths: formulary exception request (if non-formulary), prior authorization appeal (if denied for medical necessity), or trying alternative FGFR inhibitors first. Most denials stem from missing FGFR2 fusion test results or

Do You Qualify for Pemazyre (Pemigatinib) Coverage by Cigna in Washington? Decision Tree & Next Steps

Answer Box: Your Fastest Path to Pemazyre Coverage Yes, you can get Pemazyre (pemigatinib) covered by Cigna in Washington if you have unresectable/metastatic cholangiocarcinoma with FGFR2 fusion/rearrangement and prior systemic therapy. The fastest path: 1) Confirm FGFR2 testing is complete, 2) Submit Cigna's prior authorization with

Get Pemazyre (Pemigatinib) Covered by Anthem Blue Cross Blue Shield Virginia: Forms, Appeals & Prior Authorization Guide

Answer Box: Getting Pemazyre (Pemigatinib) Covered in Virginia Pemazyre (pemigatinib) requires prior authorization from Anthem Blue Cross Blue Shield Virginia for cholangiocarcinoma with FGFR2 fusion. The fastest path: (1) Have your oncologist submit the PA request through Availity's Interactive Care Reviewer portal with FGFR2 testing results and prior

Lowering Out-of-Pocket for Pemazyre (Pemigatinib) with UnitedHealthcare in New Jersey: Copay, Tiering & Assistance

Answer Box: Getting Pemazyre (Pemigatinib) Covered by UnitedHealthcare in New Jersey Pemazyre (pemigatinib) requires prior authorization from UnitedHealthcare and is placed on the specialty tier through OptumRx. Your first step is ensuring your oncologist has documented FGFR2 fusion/rearrangement (for cholangiocarcinoma) or FGFR1 rearrangement (for myeloid/lymphoid neoplasms) via molecular